Novo Nordisk inks $2.2B deal to develop weight-loss pill to rival Lilly’s orforglipron
Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last month.
Medical Research
-
Why Lilly is pouring billions into LEAP
In recent years, the pharmaceutical manufacturer has seen dizzying growth in its pipeline for a wide range of diseases. And modes of drug delivery are becoming increasingly complex.
Read More -
IU medical school lands record $243M in NIH funding in 2023
The Indianapolis-based medical school ranked 29th in the country for landing funding from the National Institutes of Health.
Read More -
AI tools are helping researchers discover new drugs more quickly
During the last nine years, the cumulative amount of AI investments across the pharma and biotech sectors has increased by almost thirtyfold, to $24.6 billion as of last December.
Read More -
Lilly stock skyrockets, raising profile of city’s life sciences sector
The pharmaceutical company has launched 20 drugs in the past decade to treat diseases from arthritis and psoriasis to diabetes and cancer. In recent months, Lilly has overtaken every competitor to become the most valuable drugmaker in the world.
Read More
Articles
Roche picks Indiana for new plant, expanded operations as part of $50B investment in United States
Roche said Indiana would receive a new manufacturing facility for continuous glucose monitoring and expansion and upgrades at existing pharmaceutical, diagnostics and distribution operations.
Study co-authored by IU researcher finds generic drugs made in India have more severe adverse events
The results showed that the number of severe adverse events for patients was 54.3% higher than that of drugs made in emerging economies.
Federal judge blocks ‘catastrophic’ Trump administration cut to NIH grant funding
A judge on Monday prevented the National Institutes of Health from changing the percentage that universities and medical schools are paid in facilities and administrative costs in 22 states.
NIH cuts billions of dollars in biomedical funding, effective immediately
The National Institutes of Health said the change would save more than $4 billion a year, effective immediately.
Cook Group president: New IU LAB vital for Indiana health care research
Pete Yonkman, president of Cook Group and Cook Medical, was among the speakers Monday at the official launch of the new Indiana University IU Launch Accelerator for Biosciences, or IU LAB.
Q&A with Kristin Sherman: Life sciences veteran is fighting for women’s health
Kristin Sherman leads startup Kovina Therapeutics, which is still in the early stages of developing ways to stop human papillomavirus infections before cancer develops and to treat HPV cancers after detection.
Their remains were found decades ago. A new push could identify all of a serial killer’s victims.
Family members, a determined coroner and state researchers are behind a renewed effort to identify all of the unknown dead whose remains are among some 10,000 bones and fragments unearthed on Herbert Baumeister’s suburban Indianapolis property.
Regenstrief researcher co-leading $16M Alzheimer’s research program
Kosali Simon, an Indiana University and Regenstrief Institute researcher, will study the treatment and outcomes of patients with Alzheimer’s and related dementias.
GeniPhys builds momentum with wound care technology
After 10 long years, the company that has developed a collagen biomaterial to help heal tissue is readying itself for its next big steps: regulatory approval and commercial launch.
New federal agency kickstarts Indiana kidney project with $44M award
Sen. Todd Young visited the 16 Tech innovation district Monday to underscore the work of a young federal agency that wants to shake up the conventional model of funding biomedical research.
IU, Indiana Biosciences Research Institute partner on new personalized medicine center
The Joint Center of Excellence for Point of Care Precision Medicine aims to develop better personalized care for patients with diabetes, cancer, Alzheimer’s disease and pediatric rare disease.
Lilly opens new 12-story, $700M R&D center in Boston
Lilly is moving about 200 scientists and researchers who had worked in nearby Cambridge, Massachusetts, to the new center, and plans to add about 300 employees.
Purdue, Lilly establish medical-focused research center
The Eli Lilly and Co. and Purdue University Research Alliance Center involves more than 50 researchers and 65 graduate students.
OneHealth designation could drive innovation in Elanco/Purdue space
State and corporate leaders believe a tech park taking shape on the western edge of downtown could be a launchpad for health sciences innovation and commercialization as part of the state’s ambitious economic development portfolio.
Chemo drug cisplatin increases risk of long-term hearing loss, IU researchers find
The study followed a group of testicular cancer survivors for an average of 14 years, revealing that 78% experience significant difficulties in everyday listening situations.
New director for IU Indy bioscience institute sets precision medicine as major goal
James Lin, a biomedical researcher who has focused on new innovations for tissue engineering and regenerative medicine, will start his new job in Indianapolis on Aug. 26.
FDA to bring lab tests under federal oversight in bid to improve accuracy, safety
The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
NICO Corp. gets big neurosurgery win, ponders company’s future
Indianapolis-based NICO recently wrapped up a large clinical trial that tested the company’s minimally invasive tools and technology for brain surgery in patients with hemorrhagic stroke. Now it faces a major decision.
IU lands $20M donation to establish lung cancer research center
The gift, announced Tuesday morning, is from local philanthropist Julie Wood, in honor of her late husband, Tom Wood, a prominent car dealer who died of lung cancer in 2010 at age 78.